| 1/3 | US=9-A / Ginecologia Dorigo O, Mertínez-Maza O, Berek JS. Biologic, targeted, and immune therapies. In: Berek JS, Hacker NF. Berek and Hacker's gynecologic oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2009. p. 41-56. ISBN 978-0-7817-9512-8. ONCOLOGIA GINECOLOGICA; TERAPIAS BIOLOGICA; IMUNOTERAPIA; ANGIOGENESE; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDORES DO RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; HER-2/NEU; COMPONENTES DO SISTEMA IMUNOLOGICO |
| 2/3 | US=14 / Câncer Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A. HER-2/neu I1e655val polymorphism and the risk of breast cancer. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 84-94. ISBN 978-1-57331-700-9. |
| 3/3 | US=23 / Câncer Esposito NN, Dabbs DJ. Phyllodes tumours of the breast: prognostic assessment using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 263-73. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; AVALIACAO PROGNOSTICA; MARCADORES DE PROLIFERACAO CELULAR; GENES SUPRESSORES DE TUMOR; P53; RECEPTORES DE ESTEROIDES; PROTEINAS; FATORES DE CRESCIMENTO EPIDERMICO; HER-2/NEU; ANALISE CROMOSSOMICA; ANALISE MOLECULAR; ANALISE HISTOPATOLOGICA |